Clinical Trial Detail

NCT ID NCT02936206
Title Examination of Breast Cancer Cells of Pre-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements yes
Sponsors Icahn School of Medicine at Mount Sinai
Indications

Her2-receptor negative breast cancer

Therapies

Tamoxifen

Fulvestrant

Age Groups: adult

Additional content available in CKB BOOST